UNITED STATES SECURITIES AND EXCHANGE COMMISSION|
Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company
XNAS:REGN Regeneron Pharmaceuticals Inc Insider Activity 4 Filling
Regeneron Pharmaceuticals Inc XNAS:REGN Stock - Get Insider Activity SEC Filing of Regeneron Pharmaceuticals Inc XNAS:REGN stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.